Status:
WITHDRAWN
Relaxation Therapy in Pediatric Oncology
Lead Sponsor:
Geisinger Clinic
Conditions:
Pediatric Cancer
Eligibility:
All Genders
6-20 years
Phase:
NA
Brief Summary
This study will look at the use of relaxation therapy in children with cancer. The study will compared patients who are current receiving treatment for their cancer and those who are currently in remi...
Detailed Description
Rationale: The utilization of complementary therapies in the management of cancer have not been extensively studied in the pediatric population. Patients in active treatment and even those in remissio...
Eligibility Criteria
Inclusion
- Current patient at Geisinger Foss Clinic - oncology department with a diagnosis of cancer for more than 2 months prior to the study start
Exclusion
- Current use of any psychiatric medications including those for anxiety, depression or mood disorders
- Non-English speaking
- Patients receiving palliative care
- Patients with Langerhans' cell histiocytosis, benign teratomas and craniopharyngioma as they do not clearly constitute malignancy
- Patients with a history of cognitive developmental delay
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04719416
Start Date
September 1 2022
End Date
July 1 2023
Last Update
September 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger Medical Center
Danville, Pennsylvania, United States, 17822